Trials / Completed
CompletedNCT01828528
Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease
The Impact of Bariatric Surgery on Nonalcoholic Fatty Liver Disease and Cardiovascular Risk Utilizing Non-invasive Measures
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 26 (actual)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effect of weight loss rate on liver steatosis, steatohepatitis, fibrosis and cardiovascular risk at different stages before and after bariatric surgery. The investigators also aim to study the short-term effect of bariatric surgery on gastric cholecystokinin levels before and 10 days after the bariatric surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Sleeve gastrectomy | An intra-operative liver biopsy was performed in 20 patients |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2013-04-10
- Last updated
- 2016-11-28
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01828528. Inclusion in this directory is not an endorsement.